COPD Clinical Trial
Official title:
The Clinical Effect of Inhaled Corticosteroid Withdrawal in Chronic Obstructive Pulmonary Disease (COPD) Patients
According to the WISDOM study, withdraw of inhaled steroids has no effect on the acute
exacerbation of chronic obstructive pulmonary disease (COPD), but the lung function of
patients with COPD is significantly reclined. In the subgroup analysis of this study,
patients with COPD were found to have continued to use inhaled steroids in patients with
eosinophilic leukocytes greater than 400 cells/ul or whom has more than two episodes of
exacerbation per year. However, in SUNSET study, it was pointed out that withdraw of inhaled
steroids had no effect on lung function in patients with COPD, but it was also found that in
patients with COPD, eosinophilic leukocytes in the blood were greater than 300 cells/ul, have
a better therapeutic response in steroid inhalation. In addition, some studies have shown
that in patients with COPD, a decline in lung function after discontinuation of inhaled
steroids can make the patient's clinical symptoms worse and increase the risk of acute
exacerbations. However, in other comprehensive analytical studies, there are different
outcomes. There is no statistically significant difference in the risk of acute exacerbation
in patients with COPD after discontinuation of inhaled steroids.
In past studies, it was noted that inhaled steroids cause an increased risk of pneumonia in
patients with COPD. However, in these studies, the diagnosis of pneumonia was only from the
clinician's suspicion without clear symptom assessment, laboratory examination,
microbiological evidence or imaging assessment. Therefore, further research is needed to
assess whether patients are suitable for the reduction of inhaled steroids and the impact of
COPD in clinical treatment.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06000696 -
Healthy at Home Pilot
|
||
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
| Completed |
NCT04105075 -
COPD in Obese Patients
|
||
| Recruiting |
NCT05825261 -
Exploring Novel Biomarkers for Emphysema Detection
|
||
| Active, not recruiting |
NCT04075331 -
Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial
|
Phase 2/Phase 3 | |
| Terminated |
NCT03640260 -
Respiratory Regulation With Biofeedback in COPD
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|
||
| Withdrawn |
NCT04210050 -
Sleep Ventilation for Patients With Advanced Hypercapnic COPD
|
N/A | |
| Terminated |
NCT03284203 -
Feasibility of At-Home Handheld Spirometry
|
N/A | |
| Recruiting |
NCT06110403 -
Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT06040424 -
Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients
|
Phase 3 | |
| Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
| Recruiting |
NCT04868357 -
Hypnosis for the Management of Anxiety and Breathlessness During a Pulmonary Rehabilitation Program
|
N/A | |
| Completed |
NCT01892566 -
Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV
|
N/A | |
| Completed |
NCT04119856 -
Outgoing Lung Team - a Cross-sectorial Intervention in Patients With COPD
|
N/A | |
| Completed |
NCT04485741 -
Strados System at Center of Excellence
|
||
| Completed |
NCT03626519 -
Effects of Menthol on Dyspnoea in COPD Patients
|
N/A | |
| Recruiting |
NCT04860375 -
Multidisciplinary Management of Severe COPD
|
N/A |